RUA Life Sciences (FRA:AOHA) Long-Term Capital Lease Obligation : €0.16 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is RUA Life Sciences Long-Term Capital Lease Obligation?

RUA Life Sciences's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.16 Mil.

RUA Life Sciences's quarterly Long-Term Capital Lease Obligation declined from Mar. 2023 (€0.23 Mil) to Sep. 2023 (€0.20 Mil) and declined from Sep. 2023 (€0.20 Mil) to Mar. 2024 (€0.16 Mil).

RUA Life Sciences's annual Long-Term Capital Lease Obligation increased from Mar. 2022 (€0.10 Mil) to Mar. 2023 (€0.23 Mil) but then declined from Mar. 2023 (€0.23 Mil) to Mar. 2024 (€0.16 Mil).

RUA Life Sciences Long-Term Capital Lease Obligation Historical Data

The historical data trend for RUA Life Sciences's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RUA Life Sciences Long-Term Capital Lease Obligation Chart

RUA Life Sciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.14

0.10

0.23

0.16

RUA Life Sciences Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.10	-	0.23	0.20	0.16

RUA Life Sciences (FRA:AOHA) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

RUA Life Sciences Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of RUA Life Sciences's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

RUA Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RUA Life Sciences PLC (FRA:AOHA) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

RUA:UK

Address

2 Drummond Crescent, Ayrshire, Scotland, Irvine, GBR, KA11 5AN

Website

https://www.rualifesciences.com

RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives the majority of its revenue from the USA and has a presence in Switzerland, Italy, the UK, and Israel.

RUA Life Sciences Headlines

No Headlines